Pacira BioSciences (PCRX) EBITDA (2010 - 2026)
Pacira BioSciences (PCRX) EBITDA from Jun 30, 2010 to Mar 31, 2026. The TTM Pacira BioSciences (PCRX) EBITDA is $115M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Pacira BioSciences (PCRX) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | -4.08% |
| 5 Years TTM | +10.93% |
| 10 Years TTM | +22.02% |
Annual EBITDA change of Pacira BioSciences (PCRX)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $28M | -74.39% |
| 2025 | $110M | +1937.15% |
| 2024 | $5.41M | -96.69% |
| 2023 | $163M | +7.73% |
| 2022 | $152M | +27.91% |
| 2021 | $118M | +78.80% |
| 2020 | $66M | +120.43% |
| 2019 | $30M | +3.37% |
| 2018 | $29M | -361.98% |
| 2017 | -$11M | -41.88% |
| 2016 | -$19M | -191.26% |
| 2015 | $21M | +329.77% |
| 2014 | $4.87M | -110.24% |
| 2013 | -$48M | +8.91% |
| 2012 | -$44M | +25.47% |
| 2011 | -$35M | +86.64% |
| 2010 | -$19M | -23.61% |
| 2009 | -$24M | N/A |
Comparison Pacira BioSciences (PCRX) five years EBITDA CAGR with competitors
Pacira BioSciences (PCRX) five years EBITDA CAGR is 10.93%.